JASON HOU to Infliximab
This is a "connection" page, showing publications JASON HOU has written about Infliximab.
Connection Strength
0.401
-
Re: Lin I, Melsheimer R, Bhak RH, et al. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin. 2022;38(4):613-627. Curr Med Res Opin. 2022 12; 38(12):2241-2242.
Score: 0.193
-
Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists. Inflamm Bowel Dis. 2017 02; 23(2):254-260.
Score: 0.131
-
A 24-year-old pregnant woman with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2009 Sep; 7(9):944-7.
Score: 0.077